What is Olympus Pharmacy?
Olympus Pharmacy operates as a comprehensive, full-service pharmacy provider, specifically engineered to meet the complex needs of long-term care environments, including nursing homes and assisted living facilities. The company distinguishes itself through a multifaceted service portfolio that encompasses specialized compounding, Medication Therapy Management (MTM), and dedicated hospice support. By integrating high-touch patient care with logistical efficiency—such as local delivery and expert clinical consultation—Olympus Pharmacy bridges the gap between traditional retail pharmacy and institutional healthcare requirements. Its market position is defined by a commitment to personalized patient outcomes and operational reliability, serving as a critical partner for healthcare providers managing high-acuity patient populations.
How much funding has Olympus Pharmacy raised?
Olympus Pharmacy has raised a total of $79K across 1 funding round:
Debt
$79K
Debt (2021): $79K with participation from PPP
Key Investors in Olympus Pharmacy
PPP
Public-Private Partnership
What's next for Olympus Pharmacy?
With the infusion of this recent capital, Olympus Pharmacy is expected to prioritize the expansion of its compounding capabilities and the optimization of its supply chain infrastructure. The strategic focus will likely shift toward deepening its penetration in the long-term care market, potentially through the adoption of advanced pharmacy automation technologies and the scaling of its MTM programs. As the company matures through its current growth phase, the emphasis will remain on maintaining high-quality care standards while increasing throughput to meet the rising demand for specialized pharmacy services in aging-in-place and institutional settings. This trajectory suggests a move toward broader regional dominance and the potential for further service diversification in the coming fiscal periods.
See full Olympus Pharmacy company page
